GEMZAR INJECTION (Gemcitabine) is an antineoplastic medication used in the treatment of various types of cancer, including non-small cell lung cancer, pancreatic cancer, and bladder cancer. It works by interfering with the growth and spread of cancer cells in the body.
The dosage of GEMZAR INJECTION is determined by a healthcare provider based on the patient's condition, overall health, and response to treatment. It is typically administered once a week or every two weeks, depending on the specific treatment regimen.
Common side effects may include:
Patients should contact their healthcare provider for any severe or persistent side effects.
Inform your doctor about any allergies, current medications, and existing medical conditions.
GEMZAR may harm an unborn baby. Women who are pregnant or planning to become pregnant should discuss the risks with their healthcare provider.
GEMZAR is administered through an intravenous (IV) injection by a qualified healthcare professional.
If you miss a dose, contact your healthcare provider for guidance on when to resume treatment.